Throwing their weight around
27 October 2003

It will be a powerful counterweight to big pharma, potentially driving down drug prices which are higher in the US than elsewhere. Anthem’s $15bn acquisition of WellPoint will create a behemoth controlling health spending for 9% of the US population.